Paul Brannelly
2017 - Collegium Pharmaceutical
In 2017, Paul Brannelly earned a total compensation of $1.1M as Executive Vice President and Chief Financial Officer at Collegium Pharmaceutical, a 29% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,100 |
|---|---|
| Option Awards | $323,426 |
| Salary | $358,183 |
| Stock Awards | $248,138 |
| Other | $17,559 |
| Total | $1,096,405 |
Brannelly received $358.2K in salary, accounting for 33% of the total pay in 2017.
Brannelly also received $149.1K in non-equity incentive plan, $323.4K in option awards, $248.1K in stock awards and $17.6K in other compensation.
Rankings
In 2017, Paul Brannelly's compensation ranked 8,552nd out of 14,666 executives tracked by ExecPay. In other words, Brannelly earned more than 41.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,552 out of 14,666 | 42nd |
Division Manufacturing | 3,240 out of 5,768 | 44th |
Major group Chemicals And Allied Products | 1,079 out of 2,074 | 48th |
Industry group Drugs | 853 out of 1,730 | 51st |
Industry Pharmaceutical Preparations | 665 out of 1,329 | 50th |
Source: SEC filing on April 13, 2018.
Brannelly's colleagues
We found four more compensation records of executives who worked with Paul Brannelly at Collegium Pharmaceutical in 2017.